A Clinical Trial to Evaluate the Effects of an Electrolyte Supplement on Women's Wellness
1 other identifier
interventional
40
1 country
1
Brief Summary
This study evaluates the effects of the Daily Love Electrolytes supplement on women's wellness over a 4-week period. The primary focus is on perceived hydration and energy levels, assessed via self-reported questionnaires at Baseline, Week 1, Week 2, Week 3, and Week 4. This is a single-arm, open-label, virtual trial enrolling 40 female participants aged 18 and older who have experienced low energy and feelings of dehydration in the past four weeks. All participants will take two electrolyte tablets daily as directed throughout the 4-week study duration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 7, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 6, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 6, 2025
CompletedFirst Submitted
Initial submission to the registry
August 11, 2026
CompletedFirst Posted
Study publicly available on registry
August 14, 2026
CompletedAugust 14, 2026
August 1, 2026
7 months
August 11, 2026
August 11, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Change in Perceived Hydration
Mean change in self-reported hydration assessed via questionnaire
Baseline, Week 1, Week 2, Week 3, and Week 4
Change in Perceived Energy
Mean change in self-reported energy assessed via questionnaire
Baseline, Week 1, Week 2, Week 3, and Week 4
Secondary Outcomes (6)
Participant Perception of Hydration
Baseline, Week 1, Week 2, Week 3, and Week 4
Participant Perception of Energy
Baseline, Week 1, Week 2, Week 3, and Week 4
Participant Perception of General Feelings of Wellness
Baseline, Week 1, Week 2, Week 3, and Week 4
Participant Perception of Getting More Out of Diet and Wellness Routines
Baseline, Week 1, Week 2, Week 3, and Week 4
Participant Perception of Bloating
Baseline, Week 1, Week 2, Week 3, and Week 4
- +1 more secondary outcomes
Study Arms (1)
Daily Love Electrolytes
EXPERIMENTALInterventions
All 40 participants receive the Daily Love Electrolytes supplement. Two tablets are taken per day (one at 11am and one at 3pm), each dissolved in 16 fl.oz/475 mL of water, with or without food, for 4 weeks.
Eligibility Criteria
You may qualify if:
- Be female
- Be aged 18+
- Anyone experiencing issues regarding all of the following over the past four weeks: low energy and feeling dehydrated
- Anyone who is generally healthy - does not live with any uncontrolled chronic disease
- Willing to refrain from taking any products, prescription medications, or supplements that target energy, hydration, and general wellness during the test period
- Willing to maintain a consistent level of water intake for the duration of the study
- Willing to avoid other hydration products, including soluble products or pre-made beverages such as Pedialyte or Gatorlyte
- Willing to maintain current diet, sleep schedule, and activity level for the duration of the study
- Resides in the United States
- Not currently partaking in another research study and will not be partaking in any other research study for the next 4 weeks and at any point during this study's duration
You may not qualify if:
- Anyone with pre-existing chronic conditions that would impact participation in the study, including cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period
- Anyone with any allergies or sensitivities to any of the study product ingredients
- Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period)
- Anyone taking prescription Eskalith or Lithobid (lithium)
- Anyone taking prescription Lanoxin (digoxin)
- Anyone diagnosed with and is being treated for Parkinson's Disease with prescription medications
- Anyone taking prescription antibiotics in the study duration
- Anyone diagnosed with kidney disease
- Anyone unwilling to follow the study protocol
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Love Wellnesslead
- Citruslabscollaborator
Study Sites (1)
Citruslabs
Las Vegas, Nevada, 89101, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 11, 2026
First Posted
August 14, 2026
Study Start
April 7, 2025
Primary Completion
November 6, 2025
Study Completion
November 6, 2025
Last Updated
August 14, 2026
Record last verified: 2026-08